Mild Cognitive Impairment
Showing NaN - NaN of 17
Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Canakinumab
- Placebo
-
Charlestown, Massachusetts
- +11 more
Nov 11, 2022
Alzheimer's Disease, Cognitive Impairment, Tauopathies Trial in Worldwide (ACI-35.030, Placebo, JACI-35.054)
Active, not recruiting
- Alzheimer's Disease
- +6 more
- ACI-35.030
- +2 more
-
Helsinki, Finland
- +8 more
Jun 24, 2022
Dementia Prevention, Mild Cognitive Impairment, Subjective Cognitive Impairment Trial in Canada (Brain Health PRO)
Recruiting
- Dementia Prevention
- +3 more
- Brain Health PRO
-
Vancouver, British Columbia, Canada
- +5 more
May 26, 2022
Mild Cognitive Impairment Trial in London (PMI@Home, Brain Health Pro)
Not yet recruiting
- Mild Cognitive Impairment
- PMI@Home
- Brain Health Pro
-
London, Ontario, CanadaSt. Joseph's Health Care London, Parkwood Hospital
May 10, 2022
Early Stage Alzheimer's Disease From Acoustic and Linguistic
Recruiting
- Alzheimer Disease
- +4 more
-
Birmingham, United Kingdom
- +3 more
Apr 6, 2022
Alzheimer, Mild Cognitive Impairment, Dementia With Lewy Bodies Trial in London
Recruiting
- Alzheimer Disease
- +10 more
-
London, Greater London, United Kingdom
- +1 more
Feb 9, 2022
Mild Cognitive Impairment Trial in Canada (Vitamin D3, Exercises (E), Cognitive Training (CT))
Terminated
- Mild Cognitive Impairment
- Vitamin D3
- +5 more
-
Vancouver, British Columbia, Canada
- +4 more
Sep 30, 2021
Alzheimer, Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease Trial in United Kingdom
Completed
- Alzheimer Disease
- +4 more
-
Birmingham, United Kingdom
- +3 more
Sep 3, 2021
Mild Cognitive Impairment Trial in Worldwide (T-817MA, Placebo)
Active, not recruiting
- Mild Cognitive Impairment
- T-817MA
- Placebo
-
Brno, Czechia
- +36 more
Jun 28, 2021
Alzheimer, Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease Trial in United Kingdom
Recruiting
- Alzheimer Disease
- +4 more
-
Birmingham, United Kingdom
- +3 more
Apr 12, 2021
Alzheimer, Mild Cognitive Impairment Trial in Cambridge, London, Oxford (JNJ-40346527, Placebo)
Not yet recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- JNJ-40346527
- Placebo
-
Cambridge, United Kingdom
- +2 more
Oct 27, 2020
Gait as Predictor of Dementia and Falls. The Gait and Brain
Unknown status
- Gait Apraxia
- +5 more
-
London, Ontario, CanadaGait and Brain Lab, Parkwood Institute
Feb 27, 2020
Mild Cognitive Impairment Trial in London (Memory Self-Efficacy Training, General Education)
Unknown status
- Mild Cognitive Impairment
- Memory Self-Efficacy Training
- General Education
-
London, Ontario, CanadaCommunity
Sep 5, 2019
Mild Cognitive Impairment Trial in London (Brief Mindfulness)
Unknown status
- Mild Cognitive Impairment
- Brief Mindfulness
-
London, United KingdomSouth London and Maudsely NHS Memory Services
Sep 12, 2016
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Completed
- Mild Cognitive Impairment
- Alzheimer's Disease
-
Birmingham, Alabama
- +54 more
Sep 15, 2014
Mortality in Participants Who Participated in Previous 3 Studies
Completed
- Mild Cognitive Impairment
- No intervention
-
Tucson, Arizona
- +144 more
Apr 11, 2012